BiondVax Pharmaceuticals Ltd. (BVXV) Stock Analysis
DELISTED
What happened to BiondVax Pharmaceuticals Ltd. (BVXV) stock?
BiondVax Pharmaceuticals Ltd. (BVXV) no longer trades on public markets. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
Market cap $4.97M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
BiondVax Pharmaceuticals Ltd. (BVXV). BiondVax Pharmaceuticals Ltd. is a development-stage biopharmaceutical company based in Israel. They focus on developing, manufacturing, and commercializing products for the prevention and treatment of infectious diseases, leveraging collaborations for innovative antibody development.
Last analyzed: Mar 16, 2026BiondVax Pharmaceuticals Ltd. (BVXV) Healthcare & Pipeline Overview
BiondVax Pharmaceuticals Ltd. ADR Information Sponsored
BiondVax Pharmaceuticals Ltd. (BVXV) trades in the U.S. as an American Depositary Receipt (ADR).
- ADR Level: 2
- ADR Ratio: 1:1
More about this archive record
Can I still buy BVXV shares?
No. BVXV stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for BVXV elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before BVXV stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to BiondVax Pharmaceuticals Ltd.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.